2022—2025年天津市某医院A族链球菌特征与来源疾病相关分析

Characteristics of Streptococcus A and associations with clinical diseases in a hospital in Tianjin, 2022-2025

  • 摘要:
    目的  调查2022—2025年天津市某三甲医院A族链球菌(GAS)的分子流行特征与耐药特征及其与来源疾病的关联。
    方法  采用微量肉汤稀释法测定15种抗生素耐药性,应用聚合酶链式反应检测emm基因、红霉素与四环素耐药基因(ermB、ermA、mefA、tetM和tetO)和11种超抗原基因(speA、speC、speG、speH、speI、speJ、speK、speL、speM、ssasmeZ)。
    结果  223株GAS共分为11个emm亚型,以emm 12.0型(67.26%)和emm 1.0型(16.14%)为主;猩红热、脓疱病和银屑病患者中,emm亚型分离株占比的差异不具有统计学意义(P>0.05)。GAS对四环素、红霉素和克林霉素的耐药率分别为96.86%、98.65%、97.76%,但对其他抗生素均100.00%敏感。猩红热、脓疱病和银屑病患者中分离的GAS分离株对克林霉素的耐药性差异存在统计学意义(P<0.05);猩红热和脓疱病GAS分离株对克林霉素耐药率为97.26%和95.45%,明显高于银屑病GAS分离株的87.10%,优势耐药基因为ermB(98.21%)和tetM(96.41%);优势超抗原基因为speG(96.41%)、smeZ(97.76%)和speC(90.13%);speA、speH、speI和speJ基因在emm1.0型和emm12.0型GAS中比较,差异均有统计学意义(P<0.05)。猩红热分离株中speG(97.95%)和smeZ(97.95%)的占比较高,银屑病分离株中speG(96.77%)、speC(96.77%)和smeZ(100.00%)的占比较高,脓疱病分离株中speC(93.18%)、speG(95.45%)和smeZ(100.00%)的占比较高。猩红热、脓疱病和银屑病患者中ssa基因的携带率差异存在统计学意义(P<0.05)。
    结论  2022—2025年天津市某医院GAS的主要流行株为emm12型和emm1型,GAS对大环内酯类、四环素和克林霉素高度耐药,以携带耐药基因tetM和ermB为主,但对其他检测抗生素敏感。超抗原基因ssa的分布、克林霉素的耐药性与疾病表现存在显著关联,为临床精准治疗和感染控制提供了重要的分子流行病学依据。

     

    Abstract:
    Objective To characterize the molecular profiles and antibiotic resistance patterns of Streptococcus A isolates collected from a grade III (A) hospital in Tianjin during 2022–2025 and their associations with clinical diseases..
    Methods The resistances to 15 antibiotics of the Streptococcus A isoaltes were detected by micro-broth dilution method. Polymerase chain reaction (PCR) was conducted for the typing of emm gene, detections of erythromycin and tetracycline resistance genes (ermB, ermA, mefA, tetM, and tetO) and identifications of 11 superantigen genes (speA, speC, speG, speH, speI, speJ, speK, speL, speM, ssa, and smeZ).
    Results In the 223 Streptococcus A isolates, 11 emm subtypes were identified, in which emm12.0 (67.26%) and emm1.0 (16.14%) were predominant. There was no differences in the proportions of the isolates with different emm subtypes in the patients with scarlet fever, impetigo and psoriasis (P >0.05). The resistance rates of the Streptococcus A isolates to tetracycline, erythromycin, and clindamycin were 96.86%, 98.65% and 97.76%, respectively, while all the Streptococcus A isolates were sensitive to all other tested antibiotics. THe differences in clindamycin resistance among the Streptococcus A isolates from scarlet fever, impetigo, and psoriasis patients were significant (P <0.05) , the clindamycin resistance rates of the Streptococcus A isolates from scarlet fever and impetigo patients were 97.26% and 95.45%, respectively, higher than 87.10% in psoriasis isolates. The predominant resistance genes were ermB (98.21%) and tetM (96.41%). The predominant superantigen genes were speG (96.41%), smeZ (97.76%), and speC (90.13%). The differences in the detections of speA, speH, speI, and speJ genes were significant between emm1.0 and emm12.0 isolates of Streptococcus A (P < 0.05). The scarlet fever isolates had higher proportions of speG (97.95%) and smeZ (97.95%), the psoriasis isolates showed higher proportions of speG (96.77%), speC (96.77%), and smeZ (100.00%), while the impetigo isolates exhibited higher proportions of speC (93.18%), speG (95.45%), and smeZ (100.00%). The differences in the carriage rate of ssa gene among scarlet fever, impetigo and psoriasis patients were significant (P < 0.05).
    Conclusion During 2022-2025, the predominant Streptococcus A strains isolated in this hospital in Tianjin belonged to emm12 and emm1. The Streptococcus A isoaltes exhibited high resistance to macrolides, tetracyclines, and clindamycin, with tetM and ermB being the main resistance genes, while remained sensitive to all the other tested antibiotics. The distribution of ssa gene and clindamycin resistance exhibited significant associations with clinical diseases, which can be used important molecular epidemiological evidence for the clinical precision treatment and control of Streptococcus A infection.

     

/

返回文章
返回